Balentine LLC
RDY icon

Balentine LLC’s Dr. Reddy's Laboratories RDY Stock Holding History

Balentine LLC’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44,035
Closed -$646K – 478
2024
Q1 		$646K Buy
44,035
+1,145
+3% +$16.7K 0.02% 247
2023
Q4 		$597K Buy
42,890
+9,620
+29% +$129K 0.02% 249
2023
Q3 		$445K Sell
33,270
-55
-0.2% -$744 0.01% 284
2023
Q2 		$421K Buy
33,325
+3,130
+10% +$36.5K 0.01% 310
2023
Q1 		$344K Sell
30,195
-1,895
-6% -$20.5K 0.01% 373
2022
Q4 		$332K Buy
32,090
+5,210
+19% +$56.2K 0.01% 423
2022
Q3 		$281K Sell
26,880
-9,640
-26% -$103K 0.01% 410
2022
Q2 		$405K Buy
36,520
+7,040
+24% +$76.5K 0.01% 359
2022
Q1 		$329K Buy
+29,480
New +$334K 0.01% 404
2021
Q3 		– Sell
-15,720
Closed -$231K – 343
2021
Q2 		$231K Buy
+15,720
New +$220K 0.01% 148
2020
Q3 		– Sell
-9,140
Closed -$97K – 691
2020
Q2 		$97K Buy
+9,140
New +$93K 0.01% 155
2019
Q4 		– Sell
-3,290
Closed -$25K – 718
2019
Q3 		$25K Buy
3,290
+585
+22% +$4.35K ﹤0.01% 213
2019
Q2 		$20K Buy
2,705
+595
+28% +$4.68K ﹤0.01% 210
2019
Q1 		$17K Buy
2,110
+1,215
+136% +$9.23K ﹤0.01% 218
2018
Q4 		$7K Hold
895
– – ﹤0.01% 287
2018
Q3 		$6K Buy
+895
New +$5.98K ﹤0.01% 313

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Balentine LLC's RDY Position: Q2 2024 in Review

Balentine LLC sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 44,035 shares — an estimated $646K sold.

Balentine LLC first reported a position in RDY in Q3 2018 and held it in 16 quarters. The position peaked at $646K in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Balentine LLC reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 44,035 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $646K.
  • Balentine LLC first reported a position in Dr. Reddy's Laboratories in Q3 2018 and held it in 16 quarters.
  • Balentine LLC's Dr. Reddy's Laboratories position peaked at $646K in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.